← Back to Search

Dietary intervention and nutritional supplements (group A) for Concussion

N/A
Waitlist Available
Led By Stephanie Ward Chiasson, PhD, RD
Research Sponsored by Universite de Moncton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and endpoint (week 8)
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to assess the impact of dietary & nutritional interventions on post-concussion symptoms. Patients will be randomly assigned to receive different treatments. Symptoms will be monitored over 8 weeks.

Eligible Conditions
  • Concussion

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and endpoint (week 8)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and endpoint (week 8) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Interventional procedure
Secondary study objectives
Interventional procedure
Change from baseline in vestibular ocular motor at the end of the intervention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Physiotherapy treatment (control group)Experimental Treatment1 Intervention
Patients in the control group will receive physiotherapy treatments over eight weeks.
Group II: Dietary intervention and nutritional supplements (group A)Experimental Treatment3 Interventions
Patients in group A will receive four consultations with a dietitian over eight weeks, in addition to conventional physiotherapy treatments. These patients will receive nutritional counselling and omega-3 (2500mg/day), vitamin D (2000 IU/day) and creatine monohydrate (10mg/day) supplements prescribed by their doctor.
Group III: Nutritional supplements (group B)Active Control2 Interventions
Patients in group B will be prescribed omega-3 (2500mg/day), vitamin D (2000 IU/day) and creatine monohydrate (10mg/day) supplements and receive physiotherapy treatments over eight weeks.

Find a Location

Who is running the clinical trial?

New Brunswick Health Research FoundationOTHER
10 Previous Clinical Trials
5,875 Total Patients Enrolled
Universite de MonctonLead Sponsor
10 Previous Clinical Trials
5,131 Total Patients Enrolled
Stephanie Ward Chiasson, PhD, RDPrincipal InvestigatorUniversite de Moncton
~39 spots leftby Nov 2025